Shah Amar J, Saigal Anita, Althobiani Malik A, Hurst John R, Mandal Swapna
UCL Respiratory, University College London, UK.
Royal Free Hospital NHS Foundation Trust, London, UK.
Heliyon. 2024 Aug 5;10(16):e35474. doi: 10.1016/j.heliyon.2024.e35474. eCollection 2024 Aug 30.
Few studies have investigated the acceptability of wearable technology in patients with long-term respiratory disease. We conducted a 24-item cross-sectional survey (September 2022-February 2023), developed using four common themes universal to previously described models of technology acceptance and social behavioural therapy, to explore the acceptability of wearable technology spanning the breadth of chronic respiratory disease. A total of 74 valid survey responses were analysed with 50 % aged 51-70years; 72 % female; 63 % white British ethnicity; 79 % having an income less than £50,000, and 93 % having at least obstructive airways disease. A third of participants current used wearables with 85 % using smart watches. Most of these participants used wearables to monitor their symptoms (69 %) and as a general health measurement device (85 %). Likert scale questions (ranked 1-7) showed that participants valued accuracy and approval of wearables by regulatory bodies (median (IQR) rank score 7 (Huberty et al., 2015; Preusse et al., 2016) 6-76-7 and felt that wearables would increase their confidence in managing their long-term health condition (median (IQR) rank score 6 (Huberty et al., 2015; Preusse et al., 2016) 6-76-7. Favourable product characteristics for wearables were accuracy (73 %), easy to learn (63 %) and easy to use (50 %). They were less concerned about aesthetics (23 %) and battery life (27 %). This survey will guide future developers to produce a wearable for a population with chronic respiratory disease which will improve acceptability, usability and longevity.
很少有研究调查可穿戴技术在长期呼吸系统疾病患者中的可接受性。我们进行了一项包含24个项目的横断面调查（2022年9月至2023年2月），该调查基于先前描述的技术接受模型和社会行为疗法的四个共同主题开发，以探讨涵盖慢性呼吸系统疾病各个方面的可穿戴技术的可接受性。共分析了74份有效的调查回复，其中50%的年龄在51至70岁之间；72%为女性；63%为英国白人种族；79%的收入低于50,000英镑，93%至少患有阻塞性气道疾病。三分之一的参与者目前使用可穿戴设备，其中85%使用智能手表。这些参与者中的大多数使用可穿戴设备来监测症状（69%）并作为一般健康测量设备（85%）。李克特量表问题（评分1至7）显示，参与者重视可穿戴设备的准确性以及监管机构的批准（中位数（四分位距）评分7（休伯蒂等人，2015年；普雷斯等人，2016年）6 - 76 - 7），并认为可穿戴设备会增加他们管理长期健康状况的信心（中位数（四分位距）评分6（休伯蒂等人，2015年；普雷斯等人，2016年）6 - 76 - 7）。可穿戴设备的有利产品特性包括准确性（73%）、易于学习（63%）和易于使用（50%）。他们不太关心美观性（23%）和电池续航时间（27%）。这项调查将指导未来的开发者为慢性呼吸系统疾病人群生产出可提高可接受性、可用性和使用寿命的可穿戴设备。
